(KRON) – Genentech, a biotechnology company based in South San Francisco, is set to permanently lay off 118 employees, according to a Worker Adjustment and Retraining Notice (WARN).
The cuts are expected to take effect by November 28, and will occur across several divisions at the biotech drugmaker.
According to its website, Genentech is “dedicated to pursuing pioneering science to discover and develop medicines for people with serious and life-threatening diseases. Our transformative discoveries include the first targeted cancer antibody and the first drug for primary progressive multiple sclerosis.”
In a statement sent to KRON4 News, Genentech addressed the WARN file. “We continually evaluate all aspects of our operations to ensure we remain well-positioned to meet the evolving needs of patients today while continuing to deliver innovative new medicines into the future. This means that it is necessary, periodically, to make adjustments and decisions regarding the composition of our workforce across various functions of our company. As part of these ongoing evaluations, we have identified the need to reduce 118 positions across several divisions.”